And our language has been slyly shifted. For sure these days, whether terms like shot, 'jab', innoculation, vaccination or other language or method is used to describe their experimental Gene Therapy/Bioweapon, clearly:
'VACCINATION' DOES NOT = 'IMMUNIZATION' !!
They used to widely call getting a shot 'getting an Immunization'. As in say, for oversees travel: 'Are all your immunizations (shots) up to date?'
Such immunizations were at least widely expected to, y'know like, make you immune.
Now, in subtly-edited sites around the internet, that language has been downplayed to mean that '*immunization is a general immunizing 'process', vs. an injection that is intended to accomplish this).
It's akin to conditioning people to 'the (medical fascism) of Low Expectations'.
Perpetual Boosters, anyone?
.
But they've also been busy creating a myriad of other new 'not-really-immunizing' immunizations. To cash in, I mean heal the world of diseases.
Because it takes a world-village (i.e. full of potential injectees), to go from free cow antibodies (cowpox vaccine) to monetizing a whole proliferating herd of disease cash cows!
Um, I mean, compassionate healings. 'We are the world', and 'kumbayah', and stuff
.
[Different example/same scheme is Malaria, for anyone interested in reading more...]
http://www.inverse.com/mind-body/malaria-vaccine-new-study
There's finally a breakthrough in the hunt for a malaria vaccine
And while the world truly needs effective true cures for malaria, e.g., these proposed ‘jabs’ don’t look like they will ‘immunize’ anyone (let alone cure) over the long term:
[... hmm, and didn’t Gates or someone just altruistically release his special brand of genetically/(genocidally?) modified mosquitos into Florida or something? Without people’s actual informed consent? Naughty. What else might they be planning - maybe towards creating a new market in America for malaria + other vaccines?…]
NOTE the TIME-LIMITED ‘therapeutic’ EFFECT [love those repeat customers!] for each of these proposed moneymakers:
http://www.inverse.com/mind-body/malaria-vaccine-new-study There's finally a breakthrough in the hunt for a malaria vaccine
‘… Brandon Wilder is a malaria researcher and Assistant Professor at Oregon Health and Science University's Vaccine and Gene Therapy Institute, and was not involved in the new study. Wilder tells Inverse that there are three main malaria vaccine candidates currently undergoing late-stage trials:
-
Mosquirix: This is similar to the Covid-19 Novavax vaccine. You take a protein from the pathogen and mix it with something designed to anger the immune system, which then produces antibodies that attach to the parasite and prevent it from entering a cell — in this case, the liver which is where the parasite first begins infection. Wilder says Mosquirix looks to be about “30 to 50 percent effective,” though immunity wanes over time.
-
R21: this candidate is also similar to the COVID-19 Novavax vaccine and targets the same parasite protein, but has been shown to create a higher level of antibodies than Mosquirix: it reduces disease up to 75 percent for a full year, the first time [???] any vaccine has reached that threshold. [Uh, pardon us, but doesn't smallpox vaccine, e.g. give pretty much lifetime immunity to many people?]
-
a, b, c. Sanaria’s PfSPZ vaccine: Sanaria is a biotech company. This vaccine is different from the other two in several respects: First, there are three types. All are created using a live parasite from the mosquito’s salivary gland. Where they differ is how the parasite is weakened: For PfsPZ, the virus is irradiated. PfsPZ-GA1 uses a genetically weakened parasite that's then injected into a person. Meanwhile, PfSPZ-CVac is injected into a person who is on malaria drugs.
Duffy and his colleagues are working on PfSPZ — specifically, PfSPZ-CVac.
In contrast to Mosquirix and R21 which use antibodies to keep the parasite out of the liver, the PfSPZ vaccine can also work by targeting the parasite after liver infection with T-cells. This appears to do a better job of actually stopping all parasites from infecting rather than just keeping infection low enough to prevent disease.
What’s new — In a trial of 56 healthy adults, the researchers injected participants with PfSPZ-CVac.
The participants were also taking either pyrimethamine, which kills liver-stage parasites, or chloroquine, which kills blood-stage parasites. (You might remember chloroquine from the early days of the Covid-19 pandemic.).......
.
[And for anyone interested in reading further on the ‘classic’ aspects vs. more lucrative ‘proposed vaccine’ approaches, here’s their discussion re: **chloroquine >
http://www.inverse.com/mind-body/chloroquine
Chloroquine The strange story behind the "cure" for COVID-19 that's going viral
Chloroquine is an anti-malarial drug that has treated and prevented malaria since the 1940s. It is the subject of at least three clinical trials registered with the U.S. National Library of Medicine.
It is important to note: chloroquine does hold promise as a treatment for COVID-19. A paper published on Monday, March 16, in the journal Bioscience Trends, suggests that chloroquine is a "breakthrough treatment" for Chinese patients.
The drug has since been added to treatment guidelines in South Korea, Belgium, and China.
And our language has been slyly shifted. For sure these days, whether terms like shot, 'jab', innoculation, vaccination or other language or method is used to describe their experimental Gene Therapy/Bioweapon, clearly:
'VACCINATION' DOES NOT = 'IMMUNIZATION' !!
They used to widely call getting a shot 'getting an Immunization'. As in say, for oversees travel: 'Are all your immunizations (shots) up to date?'
Such immunizations were at least widely expected to, y'know like, make you immune.
Now, in subtly-edited sites around the internet, that language has been downplayed to mean that '*immunization is a general immunizing 'process', vs. an injection that is intended to accomplish this).
It's akin to conditioning people to 'the (medical fascism) of Low Expectations'.
Perpetual Boosters, anyone?
.
But they've also been busy creating a myriad of other new 'not-really-immunizing' immunizations. To cash in, I mean heal the world of diseases.
Because it takes a world-village (i.e. full of potential injectees), to go from free cow antibodies (cowpox vaccine) to monetizing a whole proliferating herd of disease cash cows!
Um, I mean, compassionate healings. 'We are the world', and 'kumbayah', and stuff
.
[Different example/same scheme is Malaria, for anyone interested in reading more...]
http://www.inverse.com/mind-body/malaria-vaccine-new-study
There's finally a breakthrough in the hunt for a malaria vaccine
And while the world truly needs effective true cures for malaria, e.g., these proposed ‘jabs’ don’t look like they will ‘immunize’ anyone (let alone cure) over the long term:
[... hmm, and didn’t Gates or someone just altruistically release his special brand of genetically/(genocidally?) modified mosquitos into Florida or something? Without people’s actual informed consent? Naughty. What else might they be planning - maybe towards creating a new market in America for malaria + other vaccines?…]
NOTE the TIME-LIMITED ‘therapeutic’ EFFECT [love those repeat customers!] for each of these proposed moneymakers:
http://www.inverse.com/mind-body/malaria-vaccine-new-study There's finally a breakthrough in the hunt for a malaria vaccine
‘… Brandon Wilder is a malaria researcher and Assistant Professor at Oregon Health and Science University's Vaccine and Gene Therapy Institute, and was not involved in the new study. Wilder tells Inverse that there are three main malaria vaccine candidates currently undergoing late-stage trials:
-
Mosquirix: This is similar to the Covid-19 Novavax vaccine. You take a protein from the pathogen and mix it with something designed to anger the immune system, which then produces antibodies that attach to the parasite and prevent it from entering a cell — in this case, the liver which is where the parasite first begins infection. Wilder says Mosquirix looks to be about “30 to 50 percent effective,” though immunity wanes over time.
-
R21: this candidate is also similar to the COVID-19 Novavax vaccine and targets the same parasite protein, but has been shown to create a higher level of antibodies than Mosquirix: it reduces disease up to 75 percent for a full year, the first time [???] any vaccine has reached that threshold. [Uh, pardon us, but doesn't smallpox vaccine, e.g. give pretty much lifetime immunity to many people?]
-
a, b, c. Sanaria’s PfSPZ vaccine: Sanaria is a biotech company. This vaccine is different from the other two in several respects: First, there are three types. All are created using a live parasite from the mosquito’s salivary gland. Where they differ is how the parasite is weakened: For PfsPZ, the virus is irradiated. PfsPZ-GA1 uses a genetically weakened parasite that's then injected into a person. Meanwhile, PfSPZ-CVac is injected into a person who is on malaria drugs.
Duffy and his colleagues are working on PfSPZ — specifically, PfSPZ-CVac.
In contrast to Mosquirix and R21 which use antibodies to keep the parasite out of the liver, the PfSPZ vaccine can also work by targeting the parasite after liver infection with T-cells. This appears to do a better job of actually stopping all parasites from infecting rather than just keeping infection low enough to prevent disease.
What’s new — In a trial of 56 healthy adults, the researchers injected participants with PfSPZ-CVac.
The participants were also taking either pyrimethamine, which kills liver-stage parasites, or **chloroquine **, which kills blood-stage parasites. (You might remember chloroquine from the early days of the Covid-19 pandemic.).......
.
[And for anyone interested in reading further on the ‘classic’ aspects vs. more lucrative ‘proposed vaccine’ approaches, here’s their discussion re: **chloroquine >
http://www.inverse.com/mind-body/chloroquine
Chloroquine The strange story behind the "cure" for COVID-19 that's going viral
Chloroquine is an anti-malarial drug that has treated and prevented malaria since the 1940s. It is the subject of at least three clinical trials registered with the U.S. National Library of Medicine.
It is important to note: chloroquine does hold promise as a treatment for COVID-19. A paper published on Monday, March 16, in the journal Bioscience Trends, suggests that chloroquine is a "breakthrough treatment" for Chinese patients.
The drug has since been added to treatment guidelines in South Korea, Belgium, and China.